Pasithea Therapeutics Corp. (KTTAW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
アナリスト予想 一株当たり利益（EPS） $-1.50 および 売上高 $0.00B 来期予想.
一株当たり利益（EPS）実績推移: 2024: 実績 $-12.69 vs 予想 $-1.50 (下回る -745.7%). 2025: 実績 $-2.91 vs 予想 $-0.68 (下回る -327.9%). アナリスト精度: 18%.
